Market Overview 

Market Research Future (MRFR) says that the global gene expression analysis market could hold the value of USD 3.250 million by 2023. The market could also achieve a CAGR of 9.1% during the forecast period (2018-2023).

Growth Boosters and Key Restraints 

Personalized medicine, with its ability to affect diagnostic and treatment decisions for every patient, has brought an evolution in modern medicine. Diagnosis, treatment, as well as lifestyle interventions, have now become progressively personalized to every patient genetics, family history along with other factors. 

Technologies have made it easier for healthcare professionals to track every patient’s health information and offer personalized care. Personalized medicine has gained immense traction as a result of the boost in the number of genetic disorders. Additionally, the mounting awareness about this form of treatment will drive the market in the near future. The rising technological advancement including molecular services and NGS are uplifting the demand for gene expression services. This factor will ensure the success of the gene expression analysis market report during the evaluation period.

The downside could be the high cost of instruments, hindering the market growth in the review period. But the development of genomic databases, surge in government funding towards genomics, and increasing personalized medicine are projected to elevate the market position in the subsequent years.

Rising Investments in Gene Expression Analysis Researches 

With single cell gene expression, genetic modifications recorded in animals like mice has given way to advancements in drug discover as well as development, clinical diagnostics and biotechnology, among others. Companies along with research institutes are working on projects based on gene expression analysis. These projects are seeing massive success backed by high investments as the demand for nucleic acid analysis, gene cloning analysis, and other related microbiological methods is rising. 

Leading Vendors

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Pacific Biosciences of California, Inc., Illumina, Inc., Genotypic Technology Pvt Ltd, Danaher, QIAGEN, Oxford Gene Technology, Thermo Fisher Scientific, BGI, PerkinElmer Inc., Macrogen Inc., Eurofins Scientific, are some of the companies currently leading the worldwide gene expression analysis market.

Market Segmentation 

The global market for epigenetics drugs has been segmented on the basis of product, services, application, and end-user.

The market, product-wise, include consumables and instruments.

Depending on consumables, the market covers reagents and DNA chips.

Instruments-based segments in the market are polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and others.

The services mentioned in the report are gene expression profiling services, sequencing services, bioinformatics solutions, and others.

Regional Outlook 

The primary markets for gene expression analysis are Europe, Asia Pacific, Middle East Africa and the Americas.

During the forecast period, the Americas could very well reach the top position in the global gene expression analysis market, estimates MRFR. The highly-established infrastructure, huge expenditure, and increasing research and development activities in the region play a big role in this growth. The market also gets a boost from the large number of established players based in the region. Case in point is GE Healthcare, which alone generated revenue of USD 19.1 Billion in 2017.

Standing at the second spot, Europe is now an established region in the global gene expression analysis market. The regional market gains from the numerous government initiatives taken in research and development associated with gene expression analysis. Europe is also inundated with esteemed companies such as F. Hoffmann-La Roche Ltd. To illustrate, F. Hoffmann-La Roche, in February 2018, had received an approval from the U.S. Food and Drug Administration (FDA) for its multiplex Factor V and Factor II assessment which could be used on Cobas 4800 systems. This system is known for achieving real-time PCR analysis for high volume labs.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.